semaglutide family history of thyroid cancer (Ozempic) carries FDA warnings for C-cell tumors based on rodent studies, with emerging human data showing higher thyroid risk in early users. Over 2,900 lawsuits allege inadequate warnings for Familial Risk Factors in Thyroid

Common issues include nausea and diarrhea, but complications can also extend to conditions such as gastroesophageal reflux disease, gastroparesis (paralysis of the stomach), and colonic inflammation

J Endocrinol 219:5968 [DOI] [PubMed] [Google Scholar] 45.Mieczkowska A, Mansur S, Bouvard B, Flatt PR, Thorens B, Irwin N, Chappard D, Mabilleau G (2015) Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength

Ozempic is not recommended for individuals with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or certain pancreatic conditions

Suddenly Stopping the Medication Can cause withdrawal symptoms